GLP-1RAs, such as lixisenatide, not only rely on -cell function and glucagon suppression, but also assist to lower glucose by other (insulin-independent) mechanisms such as delayed gastric emptying, underlying the clinical utility of GLP-1RAs as adjuvant therapy to basal insulin in longstanding T2DM [14]
Pyrroloquinoline Quinone (PQQ) Patrick supplements with 20 mg of PQQ, citing the antioxidants potential to improve mitochondrial function, increase cognition, and reduce inflammation
By contrast, Lemon Bottle is a newer fat-dissolving injectable gaining traction for its claim of fast-acting results
Retrieved from: Pekala, J
Studied for its effects on learning and memory enhancement in aging populations
Current and emerging strategies for management of myelodysplastic syndromes